Grants to attend ECCO 2015 congress on cancer

The European School of Oncology (ESO) together with the European CanCer Organisation (ECCO) offers grants to up to 15 European health journalists to attend the ECCO 2015 Congress.

 

Although plenty of advanced science will be discussed, this Congress mainly focuses on issues that are of greatest concern to patients and professionals – skills, organisation, patient involvement, how clinical trials are conducted etc. It is a very practical Congress that should be of great help to any journalist interested in reporting on cancer – one of the greatest challenges for medicine, health care, social care and for good journalism.

 

 

Attending the Congress is not a sightseeing visit – it is hard work but very productive. Journalists who are supported by ESO will be expected to attend the Congress and special events, and to follow up on stories. But it is also friendly and fun and an opportunity to share experiences with like-minded colleagues.

There are a limited amount of fellowships available. Successful candidates will receive:
4 night’s accommodation arranged by ESO (26, 27, 28 and 29 September)
a grant of up to 500 euros (max) for travel/transfers (travel must be arranged by the participant, it will be refunded after the congress and on production of travel receipts)
a per diem of 30 euros per day for food (to be refunded after the congress)

Eligible journalists are:
Early and mid-career journalists, freelance or staff, covering health stories in print/broadcast/online mass media, who would not normally have the chance to attend ESMO Congress
From any country within the WHO Europe region
With an interest in reporting on medical progress from the perspective of the practical implications for patients

Reporting on Cancer
ESO @ ECCO2015 Fellowship
25 September – 29 September 2015 Congress Centre Messe, Vienna, Austria

The deadline for applications is 15 July 2015

All the details, and the instructions to apply are available on the website of Cancerworld/European School of Oncology.